Renewed hope for a Greek deal boosted the markets to a sharply higher close with the Dow soaring 138 points to 17,757. Nasdaq climbed 26 points to 5,013.

On the upside

Shares of SciClone Pharmaceuticals (Nasdaq: SCLN) extended its gains.

Bank of America Merrill Lynch upgraded Schnitzer Steel Industries (Nasdaq: SCHN) from an Underperform rating to a Buy rating.
 
Blue Ridge Capital acquired an 8.32% stake in Fitbit (Nasdaq: FIT).

On the downside

Real Goods Solar (Nasdaq: RGSE) completed its $5 million public offering.

Teva Pharmaceuticals (NYSE: TEVA) and Xenon Pharmaceuticals (Nasdaq: XENE) reported disappointing results from a Phase 2b study of their chronic osteoarthritis pain treatment TV-45070.

TriMas (Nasdaq: TRS) closed an amendment to existing credit facilities.
 
In the broad market, advancing issues outpaced decliners by a margin of 5 to 3 on the NYSE and by more than 10 to 9 on Nasdaq. The broader S&P 500 climbed 14 points to 2077. Bitcoin slipped $3 to $259.